Sign In
Buy TTOO
$0.0020
+0 (+0%)
At Close: Jun 03, 2026
T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel
12:00pm, Monday, 11'th Jul 2022 GlobeNewswire Inc.
Molecular Diagnostic Test for Early Detection of Lyme Disease Molecular Diagnostic Test for Early Detection of Lyme Disease
Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch
09:25am, Monday, 11'th Jul 2022
More penny stocks to watch under $1 The post Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
02:04pm, Thursday, 07'th Jul 2022 Benzinga
Upgrades
For Pacific Premier Bancorp Inc (NASDAQ:PPBI), Raymond James upgraded the previous rating of Outperform to Strong Buy. In the first quarter, Pacific Premier Bancorp showed an EPS of $0.70, co
Coinbase, Moderna And 56 Biggest Movers From Yesterday
08:42am, Thursday, 07'th Jul 2022 Benzinga
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-ti
Dow Jumps More Than 100 Points Following Release Of Fed Minutes
07:00pm, Wednesday, 06'th Jul 2022 Benzinga
U.S. stocks traded higher toward the end of trading, following the release of minutes from the recent Federal Reserve meeting, which suggest inflation remains the central bank's top priority. The c
U.S. Stocks Turn Lower; Amazon Acquires This Much Stake in Grubhub
04:12pm, Wednesday, 06'th Jul 2022 Benzinga
U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 150 points on Wednesday. Investors are awaiting minutes from the recent Federal Reserve meeting.
The Dow traded d
Why Is DoorDash Down By 8%? 38 Stocks Moving In Wednesday's Mid-Day Session
04:08pm, Wednesday, 06'th Jul 2022 Benzinga
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time chang
T2 Biosystems Shares Slide As Interim Q2 Sales Trail Consensus
10:35am, Wednesday, 06'th Jul 2022
T2 Biosystems Inc (NASDAQ: TTOO) expects Q2 FY22 revenues of $5.8 million - $6.1 million, below the consensus of $6.87 million. The interim numbers include product revenue of $2.5 million - $2.7 mil
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
08:23am, Tuesday, 28'th Jun 2022 Benzinga
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Acutus Medical, Inc. (NASDAQ: AFIB) climbed 87.6% to cl
T2 Biosystems to Appear on the Benzinga All Access Show on June 17, 2022
08:05pm, Wednesday, 15'th Jun 2022 GlobeNewswire Inc.
LEXINGTON, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced p
T2 Biosystems Receives Nasdaq Extension to Comply with Bid Price Rule; Company to Transfer to Nasdaq Capital Market
01:00pm, Friday, 10'th Jun 2022 GlobeNewswire Inc.
LEXINGTON, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today th
T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease
01:17pm, Friday, 20'th May 2022 GlobeNewswire Inc.
LEXINGTON, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the
T2 Biosystems, Inc. (TTOO) CEO John Sperzel on Q1 2022 Results - Earnings Call Transcript
11:08pm, Thursday, 05'th May 2022
T2 Biosystems, Inc. (NASDAQ:TTOO ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Malcolm MacLeod - IR Philip Taylor - Gilmartin Group John Sperzel - Chairman and CEO Joh
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
12:30pm, Wednesday, 27'th Apr 2022 GlobeNewswire Inc.
LEXINGTON, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today
T2 Biosystems to Report First Quarter 2022 Financial Results on May 5, 2022
08:05pm, Thursday, 21'st Apr 2022 GlobeNewswire Inc.
LEXINGTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today
